『October 8, 2026 - The Uncertain Quality of Peptides - Deep Dive with Alex and Jessica』のカバーアート

October 8, 2026 - The Uncertain Quality of Peptides - Deep Dive with Alex and Jessica

October 8, 2026 - The Uncertain Quality of Peptides - Deep Dive with Alex and Jessica

無料で聴く

ポッドキャストの詳細を見る

Title: October 8, 2026 - The Uncertain Quality of Peptides - Deep Dive with Alex and Jessica

Keep the momentum at: https://www.v2u.us/subscribe

If you’ve found this episode informative, insightful or beneficial, don’t forget to like and share with someone who may also benefit.

Primary Keyword Cluster: peptide gray market, certificates of analysis, BPC-157, 503B compounding pharmacy, peptide quality testing

Description: Alex and Jessica unpack a polished online peptide order that cost more than $600, arrived with official-looking paperwork, and then failed an independent US lab. They trace forged certificates, a steroid-laced supplement scandal, wrong fills, repeated swaps to cheaper semaglutide, and nasal sprays that cannot be absorbed. The episode then contrasts that gray market with the sourcing, retesting, and recall power of a regulated 503B compounding pharmacy.

• The $600 Lab Failure: Dr. Ashley Frost bought popular vials, including BPC-157 and CJC-1295, from a supplier in China. The packaging and certificates looked flawless, but an independent US lab found none of the labeled peptides. Every vial failed, and the shipment went in the trash.

• Forged Paper, Wrong Drugs, and Useless Sprays: Certificates of analysis in this market can be nothing more than a PDF. Raphael Mazur of Findrich describes independent mass spectrometry that buyers can actually check. The episode also covers Paradigm Peptides, hidden anabolic steroids and steroid-induced psychosis, Google rankings that only prove SEO, fills that run short or about 30 percent high, repeated substitution with cheaper semaglutide, and nasal products whose molecules are too large to enter the bloodstream.

• 503B Oversight Versus No Recourse: Sean Norian of Empower Pharmacy explains 503B sourcing from FDA-registered suppliers, quarantine, and in-house tests for identity, purity, heavy metals, residual solvents, and endotoxins. That system can recall a bad batch. A gym back room, a bodega counter, or an anonymous overseas factory cannot, and scammers aim at people who are exhausted and ready to trust a slick site.

Timestamps: • 0:00 – Five Vials of Literal Garbage

• 1:20 – The $600 Order from a China Supplier

• 2:21 – A 100 Percent Failure Rate

• 3:01 – Certificates of Analysis and the Paper Shield

• 4:43 – Paradigm Peptides and Hidden Steroids

• 7:05 – Wrong Fills, Overfills, and Drug Swaps

• 9:47 – Nasal Sprays the Body Cannot Absorb

• 11:08 – Sean Norian on Empower and 503B Oversight

• 13:09 – Gym Fridges, Bodegas, and Zero Recourse

• 15:52 – Scammers, Promise, and No Safety Net

Don't miss our next episode, where we'll continue to unravel the latest in AI innovation and market trends.

Tags and Keywords: #peptidegraymarket, #peptides, #BPC157, #CJC1295, #certificateofanalysis, #compoundingpharmacy, #503Bpharmacy, #semaglutide, #peptidesafety, #unregulatedpeptides,

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません